ELOXX PHARMAC.NEW  DL-,01
ELOXX PHARMAC.NEW DL-,01
Share · US29014R2022 · ELOX · A3DXL9 (XFRA)
Overview Financial Indicators
0,00009 EUR
Frankfurt (XNAS) · Current prices and charts at MoneyPeak
04.06.2025 18:23

Current Prices from ELOXX PHARMAC.NEW DL-,01

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
ELOX
USD
04.06.2025 18:23
0,0001 USD
0,0001 USD

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,29 % 0,00 % -1,56 % -5,14 % -7,84 % -99,99 % -100,00 %

Company Profile for ELOXX PHARMAC.NEW DL-,01 Share

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts.

Company Data

Name ELOXX PHARMAC.NEW DL-,01
Company Eloxx Pharmaceuticals, Inc.
Symbol ELOX
Website https://www.eloxxpharma.com
Primary Exchange XFRA Frankfurt
WKN A3DXL9
ISIN US29014R2022
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Sumit Aggarwal M.B.A.
Country United States of America
Currency EUR
Employees 0,0 T
Address 480 Arsenal Way, 02472 Watertown
IPO Date 1999-04-26

ID Changes

Date From To
31.01.2018 SVON ELOX

Ticker Symbols

Name Symbol
NASDAQ ELOX

More Shares

Investors who ELOXX PHARMAC.NEW DL-,01 hold also have the following shares in their portfolio:
FinWise Bancorp - Common Stock
FinWise Bancorp - Common Stock Share
PROXIMUS S.A.
PROXIMUS S.A. Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025